Markel Corporation (MKL)
Official siteFINANCIAL SERVICES • INSURANCE - PROPERTY & CASUALTY • NYSE
Market Cap: $24.18B
Last updated: Nov 17, 2026 at 11:06 AM ET
Markel Corporation (MKL) Stock Forecast
Analysts expect Markel (MKL) to earn $111.40 per share in the fiscal year ending Dec 31, 2026, on revenue of $16.37B. Of 7 analysts, 1 rates the stock Buy or Strong Buy, 5 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 2.86, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 14% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 14.3% |
| Buy | 0 | 0.0% |
| Hold | 5 | 71.4% |
| Sell | 1 | 14.3% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 7.9% and revenue estimates fall 2.3%.
- Fiscal year ending Dec 31, 2026
- $111.40
- EPS consensus, revenue $16.37B
- Fiscal year ending Dec 31, 2027
- $120.21
- EPS consensus, revenue $15.99B
- Next report
- Feb 2, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $111.40 | $107.16 to $119.61 | 4 | $16.37B | $15.76B to $17.39B | 3 |
| Dec 31, 2027 | $120.21 | $114.95 to $134.08 | 6 | $15.99B | $14.73B to $17.27B | 5 |
Quarterly Estimates
The EPS consensus falls from $28.91 for the quarter ending Dec 31, 2026 to $26.92 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $28.91 | $27.33 to $31.19 | 6 | $3.86B | $3.55B to $4.30B | 5 |
| Mar 31, 2027 | $26.92 | $25.32 to $28.21 | 4 | $3.63B | $3.40B to $3.84B | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 4 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 2 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 20.3% from $92.60.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $111.40 | $97.11 | $94.08 | $94.08 | $92.60 | +20.3% |
| Fiscal year ending Dec 31, 2027 | $120.21 | $114.29 | $112.95 | $112.94 | $113.94 | +5.5% |
| Quarter ending Mar 31, 2027 | $26.92 | $27.04 | $27.20 | $27.19 | $27.68 | -2.7% |
Frequently Asked Questions About MKL
What is the MKL stock forecast?
Consensus analyst estimates put Markel's EPS at $111.40 for the fiscal year ending Dec 31, 2026, on revenue of $16.37B. The consensus rating from 7 analysts is Hold.
How do analysts rate MKL stock?
Of 7 analysts covering Markel, 1 rates it Strong Buy, 0 Buy, 5 Hold, 1 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from MKL next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $111.40, with estimates from $107.16 to $119.61 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $120.21, with estimates from $114.95 to $134.08 from 6 analysts.
What revenue do analysts expect from Markel next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $16.37B, with estimates from $15.76B to $17.39B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $15.99B, with estimates from $14.73B to $17.27B.
How many analysts cover MKL?
7 analysts rate Markel stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
MKL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts